Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine☆☆☆★

Department of Medicine, Saint Louis University, St Louis, Missouri; Department of Pediatrics, Vanderbilt University, Nashville, Tennessee; Aviron, Mountain View, California; Pittsburgh Pediatric Research, Pittsburgh, Pennsylvania; Kentucky Pediatric Research, Inc, Bardstown, Kentucky; Statistics Collaborative, Washington, DC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland; Department of Microbiology and Immunology, Baylor College of Medicine, Houston, Texas; Department of Medicine, The University of Rochester, Rochester, New York; Department of Pediatrics, University of Maryland at Baltimore; Department of Pediatrics, Children’s Hospital Medical Center, Cincinnati, Ohio; Departments of Internal Medicine and Pathology, University of Virginia, Charlottesville; Kaiser-UCLA Vaccine Program/Harbor–University of California Los Angeles Medical Center, Department of Pediatrics, Los Angeles, California; and The EMMES Corporation, Potomac, Maryland

Received 14 April 1999; received in revised form 14 July 1999 and 23 August 1999; accepted 9 September 1999.

• Abstract
• Full Text
• PDF
• Images
• References